Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

CUSIP: 23954D109

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
-1,790,886
Put/Call ratio
31%
SEC-reported price per share
$21.52
Number of holders
105
Value change
-$37,719,296
Number of buys
61
Show 1 more signal
Number of sells
28
Security identity 1 source field
Shares outstanding
103,269,345

Security key

23954D109

Report period

Q4 2022

Institutions

105

Top holders

10

Ownership snapshot

Top reported holders of DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
105
Shares
59,797,551
Rows available
105
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
87
Q4 2022 holders
105
Holder diff
18
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .